[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Cutting-Edge Reports on Pharmaceuticals Market

30 Aug 2022 • by Natalie Aster

LONDON – Market Publishers is happy to inform that a lot of novel comprehensive research reports covering various sectors of the global pharmaceuticals industry have been uploaded to MarketPublishers.com in August. Our experts have prepared a selection of the most in-demand latest research reports featuring the pharmaceuticals market available on our website:

HIV Drugs Market 

Over the years, the increasing prevalence of HIV disease across the globe has positively influenced the demand for HIV drugs. HIV drugs help to prevent the multiplication of HIV, thereby reducing the risk of its transmission. The world’s HIV drugs market crossed the value of USD 29.2 billion last year and is poised to reach USD 38.9 billion by the year 2027, expanding at a CAGR of 3.7% in the next 5 years. Apart from the rising cases of HIV worldwide, the market growth will likely be spurred by the rising government initiatives for spreading awareness amongst people regarding the causes, symptoms, and treatments of HIV disease; and the introduction of generic drugs, which are cost-effective and chemically identical to branded drugs…

Antifibrinolytic Drugs Market 

The global market for antifibrinolytic drugs is anticipated to increase at a CAGR of 4.6% between 2022 and 2027, propelled by the increasing incidence of road accidents, traumas, and various bleeding disorders; rising adoption of antifibrinolytic drugs to prevent BloodLoss in women suffering from menorrhagia and during cardiovascular and neurosurgeries; and growing awareness about available treatment options for hereditary angioedema and hemophilia. Besides, such factors as ongoing technological advancements, the introduction of innovative oral and intravenous drug variants with enhanced efficacy and bio-absorbability, rapidly aging population, and notable improvements in the healthcare infrastructure are expected to drive the global antifibrinolytic drugs market in the next 5 years. In 2027, the value of the global antifibrinolytic drugs market is projected to reach USD 20.46 billion…

Acne Drugs Market 

The global market for acne drugs is forecast to expand at a CAGR of 7.4% between 2022 and 2027, spurred by the rising prevalence of skin-related diseases, growing awareness among people regarding the benefits of using premium skin care products, and the development of effective therapeutics and treatment alternatives with reduced side effects and high potential. The soaring consumer demand for products with natural ingredients is expected to create lucrative growth opportunities for the global acne drugs market in the coming years. Furthermore, factors such as increasing expenditure capacities of consumers, and the proliferation of online retail platforms that offer customized acne drugs according to the user’s skin type are also poised to add to the market growth during 2022-2027. By the end of the forecast period, the value of the global acne drugs market is slated to reach USD 9.1 billion…

Gastroparesis Drugs Market 

The world’s market for gastroparesis drugs is slated for sustainable growth at a CAGR of 5.15% in the next 5 years and is poised to increase in value terms from USD 5.9 billion in 2021 to USD 7.8 billion by 2027. The increasing incidence of gastroparesis (aka stomach paralysis), backed by rapid urbanization, rising prevalence of sedentary lifestyles, the increasing number of individuals who drink and smoke regularly, the growing diabetic patients pool, and the increasing geriatric population, is poised to act as the major growth engine of the gastroparesis drugs market in the coming years. Besides, increasing investments in R&D by leading manufacturers to introduce new approaches to the existing drug therapy and develop advanced and effective drugs will also add to the market growth. Additionally, the improving healthcare infrastructure and the escalating demand for user-friendly drugs are anticipated to impel the growth of the gastroparesis drugs market during the forecast period…

Peptide Antibiotics Market 

The global market for peptide antibiotics was valued at around USD 4.37 billion in 2021 and is predicted to grow at a CAGR of appr. 4.6% over 2022-2028, spurred by the increasing demand for peptide antibiotics in hospitals and clinics along with the rising prevalence of health disorders such as bacterial skin infections, bloodstream infections, and hospital-acquired infections. Moreover, the increasing number of product approvals and product launches is likely to drive the market growth during the forecast period. The North American peptide antibiotics market is projected to maintain the dominant share of the global market during 2022-2028, supported by the mounting demand for antibiotics and rising R&D activities in the region…


Topical Drugs Market 


The global market for topical drugs reached the value of USD 97.42 billion in 2021 and is expected to register robust growth at a 10.1% CAGR during 2022-2028. The increasing prevalence of skin problems and diabetes, ongoing innovations in topical medication formulations, and new product launches in major areas are poised to act as the key market growth drivers. However, rising concerns regarding irritations and allergies associated with topical treatments may restrain the market growth throughout the forecast period. North America is predicted to remain the leading regional market for topical drugs during 2022-2028…


Immunotherapy Drugs Market 


The global immunotherapy drugs industry is forecast to expand at a CAGR of 6.92% between 2022 and 2030 and is poised to exceed USD 200.5 billion in value terms by the end of the forecast period. The major market growth drivers include enhancing awareness about chronic diseases including cancer, autoimmune diseases, inflammatory diseases, and infectious diseases, and supportive government policies for drug approval. Furthermore, the rising adoption of targeted therapies for chronic diseases treatment will likely drive the use of immunotherapy drugs in the coming years. The cancer segment is projected to maintain the dominant share of the overall market through 2030, supported by the increased incidence of cancer globally and improved healthcare infrastructure in low- and middle-income countries…


Many other in-demand research reports covering various segments of the pharmaceuticals industry can be found in this Market Publishers’ catalogue

Analytics & News

Weekly Digest